BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gandolfi S, Marchini G, Caporossi A, Scuderi G, Tomasso L, Brunoro A. Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma. Nutrients 2020;12:E793. [PMID: 32197303 DOI: 10.3390/nu12030793] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mastropasqua L, Agnifili L, Ferrante C, Sacchi M, Figus M, Rossi GCM, Brescia L, Aloia R, Orlando G. Citicoline/Coenzyme Q10/Vitamin B3 Fixed Combination Exerts Synergistic Protective Effects on Neuronal Cells Exposed to Oxidative Stress. Nutrients 2022;14:2963. [DOI: 10.3390/nu14142963] [Reference Citation Analysis]
2 Marchesi N, Fahmideh F, Barbieri A, Racchi M, Pascale A, Govoni S. Pharmacological Versus Non-Pharmacological and Ancillary Mechanisms in Eye Drops Used in the Treatment of Glaucoma. Front Drug Saf Regul 2022;2. [DOI: 10.3389/fdsfr.2022.933471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rossi GCM, Rolle T, De Silvestri A, Sisto D, Mavilio A, Mirabile AV, Paviglianiti A, Strano B, Picasso E, Pasinetti GM, Milano G, Ruberto G. Multicenter, Prospective, Randomized, Single Blind, Cross-Over Study on the Effect of a Fixed Combination of Citicoline 500 mg Plus Homotaurine 50 mg on Pattern Electroretinogram (PERG) in Patients With Open Angle Glaucoma on Well Controlled Intraocular Pressure. Front Med 2022;9:882335. [DOI: 10.3389/fmed.2022.882335] [Reference Citation Analysis]
4 Gromova OA, Torshin IY, Grishina TR, Demidov VI, Bogacheva TE. Molecular and Clinical Aspects of the Action of Cytidine Diphosphocholine on Cognitive Functions. Neurosci Behav Physi 2022;52:347-355. [DOI: 10.1007/s11055-022-01247-x] [Reference Citation Analysis]
5 Fragiotta S, Pinazo-durán MD, Scuderi G. Understanding Neurodegeneration from a Clinical and Therapeutic Perspective in Early Diabetic Retinopathy. Nutrients 2022;14:792. [DOI: 10.3390/nu14040792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Antsiferov OV, Cherevatenko RF, Korokin MV, Gureev VV, Gureeva AV, Zatolokina MA, Avdeyeva EV, Zhilinkova LA, Kolesnik IM. A new EPOR/CD131 heteroreceptor agonist EP-11-1: a neuroprotective effect in experimental traumatic brain injury. RRP 2021;7:1-9. [DOI: 10.3897/rrpharmacology.7.75301] [Reference Citation Analysis]
7 Storgaard L, Tran TL, Freiberg JC, Hauser AS, Kolko M. Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development. Front Med (Lausanne) 2021;8:733080. [PMID: 34589504 DOI: 10.3389/fmed.2021.733080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
8 Gromova OA, Torshin IY, Grishina TR, Demidov VI, Bogacheva TE. [Molecular and clinical aspects of the effect of cytidyndiphosphocholine on cognitive functions]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:88-97. [PMID: 34184483 DOI: 10.17116/jnevro202112105188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bergandi L, Silvagno F, Grisolia G, Ponzetto A, Rapetti E, Astori M, Vercesi A, Lucia U. The Potential of Visible and Far-Red to Near-Infrared Light in Glaucoma Neuroprotection. Applied Sciences 2021;11:5872. [DOI: 10.3390/app11135872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Porciatti V, Chou TH. Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies. Cells 2021;10:1398. [PMID: 34198840 DOI: 10.3390/cells10061398] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Hwang JS, Shin YJ. Role of Choline in Ocular Diseases. Int J Mol Sci 2021;22:4733. [PMID: 33946979 DOI: 10.3390/ijms22094733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Oddone F, Rossetti L, Parravano M, Sbardella D, Coletta M, Ziccardi L, Roberti G, Carnevale C, Romano D, Manni G, Parisi V. Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review. Pharmaceuticals (Basel) 2021;14:281. [PMID: 33804675 DOI: 10.3390/ph14030281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Marino PF, Rossi GCM, Campagna G, Capobianco D, Costagliola C, On Behalf Of Qualicos Study Group. Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study. Molecules 2020;25:E5614. [PMID: 33260376 DOI: 10.3390/molecules25235614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
14 Adornetto A, Rombolà L, Morrone LA, Nucci C, Corasaniti MT, Bagetta G, Russo R. Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma. Nutrients 2020;12:E3158. [PMID: 33081127 DOI: 10.3390/nu12103158] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Jasielski P, Piędel F, Piwek M, Rocka A, Petit V, Rejdak K. Application of Citicoline in Neurological Disorders: A Systematic Review. Nutrients 2020;12:E3113. [PMID: 33053828 DOI: 10.3390/nu12103113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
16 Saccà SC, Vernazza S, Iorio EL, Tirendi S, Bassi AM, Gandolfi S, Izzotti A. Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for neuroprotection. Prog Brain Res 2020;256:151-88. [PMID: 32958211 DOI: 10.1016/bs.pbr.2020.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]